# ScoreItem: Panturrilha (cm) - mulher

**ID:** `019bf31d-2ef0-7936-b83b-284a0f8c84eb`
**FullName:** Panturrilha (cm) - mulher (Composi√ß√£o corporal - Atual - Medidas objetivas)
**Gender:** female

**Preparation Metadata:**
- Quality Grade: **FAIR**
- Total Chunks: 30 de 13 artigos
- Avg Similarity: 0.482

---

## Contexto

Voc√™ √© um especialista em medicina funcional integrativa e est√° contribuindo com o **Escore Plenya** ‚Äî um escore completo de an√°lise de sa√∫de que avalia todos os aspectos da sa√∫de, performance e longevidade humana. Cada ScoreItem representa um par√¢metro cl√≠nico, laboratorial, gen√©tico, comportamental ou hist√≥rico que comp√µe esse escore.

Seu papel √© gerar conte√∫do cl√≠nico de alta qualidade para enriquecer cada par√¢metro do escore com relev√¢ncia cl√≠nica, orienta√ß√£o ao paciente e conduta pr√°tica.

**Regras inegoci√°veis:**
- Use **apenas** o conhecimento m√©dico real consolidado e os dados presentes nos chunks cient√≠ficos abaixo
- **N√£o alucine, n√£o invente** dados, estudos, estat√≠sticas ou refer√™ncias que n√£o estejam nos chunks ou no seu conhecimento m√©dico estabelecido
- Se um dado espec√≠fico n√£o constar nos chunks e n√£o for do seu conhecimento consolidado, **n√£o o inclua**
- Seja preciso: prefira omitir a inventar

## Instru√ß√£o

Com base nos chunks cient√≠ficos abaixo, gere as respostas em formato JSON.

**O JSON deve obrigatoriamente conter o campo `score_item_id` com o valor `019bf31d-2ef0-7936-b83b-284a0f8c84eb`.**

```json
{
  "score_item_id": "019bf31d-2ef0-7936-b83b-284a0f8c84eb",
  "clinical_relevance": "Texto t√©cnico para m√©dicos (1000-5000 chars): defini√ß√£o fisiol√≥gica precisa, valores de refer√™ncia e interpreta√ß√£o, fisiopatologia resumida, dados epidemiol√≥gicos com n√∫meros concretos, estratifica√ß√£o de risco baseada em evid√™ncias.",
  "points": 1,
  "patient_explanation": "Texto simples para pacientes (500-1000 chars): o que √© este par√¢metro sem jarg√µes, por que √© importante para a sa√∫de, o que valores alterados podem significar. Tom tranquilizador e educativo.",
  "conduct": "Conduta cl√≠nica em Markdown (1000-5000 chars): investiga√ß√£o complementar necess√°ria, crit√©rios de encaminhamento a especialistas, interven√ß√µes baseadas em evid√™ncias. Use bullet points, se√ß√µes e negrito."
}
```

**Regras para `points` (1-50):**
- Baixo impacto cl√≠nico: 1-9 pts
- Alto impacto cl√≠nico: 10-19 pts
- Alto impacto em mortalidade: 20-50 pts
- Crit√©rios: gravidade/mortalidade (40%), preval√™ncia (30%), intervencionabilidade (30%)

---

### Contexto Cient√≠fico

**ScoreItem:** Panturrilha (cm) - mulher (Composi√ß√£o corporal - Atual - Medidas objetivas)
**G√™nero:** female

**30 chunks de 13 artigos (avg similarity: 0.482)**

### Chunk 1/30
**Article:** Mastologia II (2024)
**Journal:** Pos Graduacao MFI
**Section:** results | **Similarity:** 0.542

dos sintomas gerais a investigar em consulta, como dor mam√°ria e TPM intensa, que podem indicar predomin√¢ncia estrog√™nica.

## Objetivo:
N√£o h√° achados de exame f√≠sico de um paciente espec√≠fico. A abordagem objetiva descrita inclui:
- Avalia√ß√£o da composi√ß√£o corporal por bioimped√¢ncia ou densitometria de corpo total, identificando condi√ß√µes como sarcopenia em mulheres com peso normal.
- Solicita√ß√£o de exames laboratoriais para avaliar marcadores inflamat√≥rios e verificar se a paciente est√° metabolicamente doente ou em risco.

## Diagn√≥stico Prim√°rio:
- Avalia√ß√£o: Discuss√£o educacional sobre estratifica√ß√£o de risco para c√¢ncer de mama. 90% dos casos relacionam-se ao estilo de vida e 10% a fatores gen√©ticos conhecidos. Muta√ß√µes de alta penetr√¢ncia (ex.: BRCA1, BRCA2, TP53) aumentam significativamente o risco, por√©m s√£o raras. Epigen√©tica e estilo de vida s√£o cruciais e modific√°veis.

---

### Chunk 2/30
**Article:** Abordagem Funcional Integrativa Aplicada a Cada √Årea - Parte XIX (2024)
**Journal:** Pos Graduacao MFI
**Section:** results | **Similarity:** 0.534

g/kg) e pr√°tica de exerc√≠cios de resist√™ncia para preservar massa muscular.
- [ ] 3. Todos os profissionais: Em doen√ßas cr√¥nicas sem causa org√¢nica clara ou com m√° resposta ao tratamento, investigar ativamente traumas de inf√¢ncia, estresse cr√¥nico e quest√µes emocionais n√£o resolvidas como poss√≠vel "causa primeira".
- [ ] 4. Terapeutas e psic√≥logos: Adotar "terapia de precis√£o", utilizando m√∫ltiplas ferramentas e combinando diferentes abordagens terap√™uticas para personalizar o tratamento e focar em resultados mensur√°veis, em vez de seguir uma √∫nica linha te√≥rica por longos per√≠odos.
- [ ] 5. Estudo pessoal: Pesquisar o conceito de "causa primeira" de Arist√≥teles para aprofundar a l√≥gica de buscar a origem dos problemas.
- [ ] 6. Estudo pessoal: Ler o livro de Bruce Lipton sobre a conex√£o entre mente e doen√ßas f√≠sicas.

---

## SOAP

> Data e Hora: 2025-11-17 16:33:53
> Paciente: 
> Diagn√≥stico:

## Hist√≥rico do Diagn√≥stico:
1. Hist√≥rico M√©dico: 
2.

---

### Chunk 3/30
**Article:** MFI - Reposi√ß√£o Hormonal - AULA 03 (2024)
**Journal:** Pos Graduacao MFI
**Section:** discussion | **Similarity:** 0.512

integrar faixas de refer√™ncia e propor√ß√µes hormonais (testosterona, DHT, estradiol), al√©m de limiares pr√°ticos.**
- Laborat√≥rios reportam faixas distintas de testosterona total: 200‚Äì800 ng/dL como inferior‚Äìsuperior t√≠pico; alguns usam 1200 como superior; indiv√≠duos podem atingir ‚Äúmil e tanto‚Äù, ilustrando variabilidade e limita√ß√£o de olhar um √∫nico valor atual.
- Limiar pr√°tico: acima de 500‚Äì600 ng/dL, queixas por baixa testosterona s√£o raras; em 300 ng/dL, considerar defici√™ncia, interpretando junto com DHT e estradiol.
- Exemplos de DHT: 500‚Äì600 (alto, sugere que n√£o √© falta de testosterona) e 400 (pode coexistir com testosterona baixa); estradiol: 20‚Äì25 (proporcional em testosterona baixa) e 20 (tudo certo quando proporcional), refor√ßando an√°lise de equil√≠brio hormonal.

---

### Chunk 4/30
**Article:** Fisiologia do Horm√¥nio do Crescimento Parte II (2024)
**Journal:** Pos Graduacao MFI
**Section:** results | **Similarity:** 0.506

hormonais; poss√≠vel benef√≠cio de reposi√ß√£o de GH quando h√° defici√™ncia documentada.
## Objetivo:
- N√£o h√° dados objetivos de exame f√≠sico, resultados laboratoriais individuais, nem achados de imagem de um paciente espec√≠fico; conte√∫do √© educacional e de revis√£o.
- Revis√£o de estudos cl√≠nicos:
  - Homens jovens treinados: GH 0,04 mg/kg, 5 dias/semana, n√£o aumentou hipertrofia nem for√ßa com treino resistido.
  - Indiv√≠duos mais velhos: GH + treino n√£o aumentou s√≠ntese proteica; resultados semelhantes aos jovens.
  - GH isolado, em doses fisiol√≥gicas e suprafisiol√≥gicas (7‚Äì14 UI em alguns estudos), n√£o promoveu atividade anab√≥lica muscular significativa.
  - Aumento consistente de massa livre de gordura com GH, majoritariamente por reten√ß√£o h√≠drica (reabsor√ß√£o de s√≥dio tubular), sem ganho de for√ßa ou s√≠ntese miofibrilar.

---

### Chunk 5/30
**Article:** Mastologia II (2024)
**Journal:** Pos Graduacao MFI
**Section:** methods | **Similarity:** 0.491

; uso de medicamentos/suplementos; h√°bitos de vida (alimenta√ß√£o, exerc√≠cio, √°lcool, tabaco); sa√∫de intestinal; n√≠veis de estresse/ansiedade; rede de apoio.
   - Aten√ß√£o a sintomas de predomin√¢ncia estrog√™nica: dor mam√°ria, TPM intensa; lacunas de cuidado em pacientes com altera√ß√µes fibroc√≠sticas e cistos, frequentemente n√£o acolhidas apesar de sintomas de excesso de estrog√™nio circulante.
* **Avalia√ß√£o de composi√ß√£o corporal**
   - Prefer√™ncia por m√©todos al√©m da balan√ßa: bioimped√¢ncia (utilizada pela instrutora) ou densitometria de corpo total.
   - Observa√ß√£o de sarcopenia em mulheres com peso normal e desconhecimento da condi√ß√£o; necessidade de interven√ß√£o.
* **Marcadores laboratoriais e metabolicidade**
   - Solicitar marcadores inflamat√≥rios para identificar adoecimento metab√≥lico ou risco, e para monitorar evolu√ß√£o ap√≥s interven√ß√µes.

---

### Chunk 6/30
**Article:** Serum concentrations of oxytocin, DHEA and follistatin are associated with osteoporosis or sarcopenia in community-dwelling postmenopausal women (2021)
**Journal:** BMC Geriatrics
**Section:** results | **Similarity:** 0.488

rethanonefracture.Toanalyzethechangesinvariousindicatorswithaging,subjectsweredividedintothreegroups:age65,65‚â§age<75,and75‚â§age.Gripstrength,gaitspeed,serumlevelsofDHEA,oxytocin,BMDoffemoralneckandtotalhip,andleanmassdecreasedsignificantlywithaging.Historyoffragil-ityfractureandserumlevelofT2increasedsignificantlywithage.Withincreasingage,theamountofphysicalexerciseandmilkconsumptiondecreasedsignificantly.Associationofserumbiomarkerswithbonemass,musclemassormusclestrengthadjustedforageStepwisemultivariatelinearregressionwasperformedtoassessthecorrelationbetweenbiomarkersandbonemass,musclemassandstrengthadjustedforage.TheresultsshowedthatDHEAwaspositivelyrelatedtohandgrip(Œ≤=0.403,p=0.041)andgaitspeed(Œ≤=0.58,p=0.004).Follistatin(Œ≤=‚àí0.28,p=0.01)wasnegativelyrelatedtoleanmass,andoxytocin(Œ≤=0.35,p=0.036)waspositivelyrelatedtoleanmass.Myostatin(Œ≤=0.92,p=0.021)waspositivelyrelatedtofatmass.Myostatin(Œ≤=‚àí0.31,p=0.032)andfollistatin(Œ≤=‚àí0.48,p=0.042)werenegativelyassociatedwithASM

---

### Chunk 7/30
**Article:** Serum concentrations of oxytocin, DHEA and follistatin are associated with osteoporosis or sarcopenia in community-dwelling postmenopausal women (2021)
**Journal:** BMC Geriatrics
**Section:** results | **Similarity:** 0.485

Bonemineraldensity,CTXC-telopeptidecollagencrosslinksDuetal.BMCGeriatrics         (2021) 21:542 Page6of10

fourgroupsofpostmenopausalwomenwithdifferentbonemusclestatusesandanalyzedtherelationshipsofbiomarkerswiththeriskofosteoporosisandsarcopenia.Theresultsshowedthatelevatedoxytocinlevelswereas-sociatedwithareducedriskofosteoporosis,andele-vatedDHEAlevelswereassociatedwithareducedriskofsarcopenia.However,elevatedfollistatinlevelswereassociatedwithanincreasedriskofsarcopenia.ThecurrentstudyfoundthatDHEAandoxytocinweresig-nificantlylowerinpostmenopausalwomenwithahis-toryoffragilityfracturecomparedtowomenwithoutfracture(datanotshown).Therefore,serumDHEAandfollistatinmaybebiomarkersofsarcopenia,andserumoxytocinmaybeabiomarkerofosteoporosis.Severalstudiesshowedthatphysicalexerciseinflu-encedserumlevelsoffollistatinandDHEA[33‚Äì35].Ourresultsshowedthatpostmenopausalwomenwith-outosteoporosis/sarcopeniaperformedhigherexerciselevelsthanwomenwithosteoporosis/sarcopenia.Fortheseresults,weconsider

---

### Chunk 8/30
**Article:** Serum concentrations of oxytocin, DHEA and follistatin are associated with osteoporosis or sarcopenia in community-dwelling postmenopausal women (2021)
**Journal:** BMC Geriatrics
**Section:** results | **Similarity:** 0.484

itivelycorrelatedwithLHandFSHandnegativelycorrelatedwithbonemass,musclemassandstrength.OurresultsshowedthatincreasedfollistatincoexistedwithreducedmusclestrengthandlowBMDinpatients,whichisconsistentwithFife[8],whoreportedthatcirculatingmyostatinandfollistatinwerenegativelyassociatedwithmusclemassandfunctioninelderlyDuetal.BMCGeriatrics         (2021) 21:542 Page4of10

women.Myostatinisamainnegativeregulatorofskel-etalmusclegrowth,andfollistatinisastronginhibitorofmyostatin-mediatedmusclewastingthatincreasesmusclemassandmuscleregenerationandmodulatesbonemetabolismbyaffectingactivin/myostatinsignaling.However,follistatinlevelsnegativelycorrelatedwithmusclemassinourstudy.Theaccelerator-brakehypothesismayexplainthisphenomenon[19].Highfol-listatinexpressionhasbeenobservedinresponsetounfavorablemetabolicenvironments,whichmaybe
Table1DescriptivecharacteristicsofthestudiedpopulationVariableAge<65(n=171)65‚â§Age<75(n=185)75‚â§Age(n=122)PvalueAge(years)58.0¬±4.069.21¬±2.979.8¬±3.6<0.001Ageofmeno

---

### Chunk 9/30
**Article:** Serum concentrations of oxytocin, DHEA and follistatin are associated with osteoporosis or sarcopenia in community-dwelling postmenopausal women (2021)
**Journal:** BMC Geriatrics
**Section:** discussion | **Similarity:** 0.484

stratedthathistoryoffragilityfrac-ture(novs.fracture)(OR0.30;95%CI0.05‚Äì0.71;p=0.006)andoxytocin(OR0.75;95%CI0.63‚Äì0.98;p=0.019)wereassociatedwithosteoporosis,andhistoryoffragilityfracture(novs.fracture)(OR0.45;95%CI0.01‚Äì0.86;p=0.015),milkconsumption(novs.high)(OR6.32;95%CI1.04‚Äì38.29;p=0.045),DHEA(OR0.73;95%CI0.51‚Äì0.96;p=0.032),follistatin(OR1.66;95%CI1.19‚Äì3.57;p=0.022)and25OHD(OR0.51;95%CI0.11‚Äì0.82;p=0.047)wereassociatedwithsarcopenia(Table4).DiscussionsUsingcohortsofcommunity-dwellingpostmenopausalwomeninShanghai,China,weexaminedtherelation-shipbetween13circulatingbiomarkers,includingDHEA,E2,T2,LH,FSH,myostatin,follistatin,oxytocin,BDNF,CTX,PINP,PTHand25OHD,andbonemass,musclemass,strengthandfunctiontoevaluatetheprac-ticalvalueofthesebiomarkersinclinicalpractice.FollistatinpositivelycorrelatedwithLHandFSHandnegativelycorrelatedwithbonemass,musclemassandstrength.OurresultsshowedthatincreasedfollistatincoexistedwithreducedmusclestrengthandlowBMDinpatients,whichisconsistentwi

---

### Chunk 10/30
**Article:** Serum concentrations of oxytocin, DHEA and follistatin are associated with osteoporosis or sarcopenia in community-dwelling postmenopausal women (2021)
**Journal:** BMC Geriatrics
**Section:** other | **Similarity:** 0.483

.140.24WHR(waist/hip)1.09¬±0.161.11¬±0.141.09¬±0.130.76Fatmass(kg)20.91¬±4.520.73¬±4.419.63¬±5.20.50Leanmass(kg)38.06¬±4.536.82¬±3.634.24v4.40.001ASMI(kg/m2)6.25¬±0.716.18¬±0.565.92¬±0.870.13LHLuteinizinghormone,FSHFolliclestimulatinghormone,DHEADehydroepiandrosterone,E2Estradiol,T2Testosterone,P1NPN-terminalpropeptideoftypeIcollagen,CTXCross-linkedC-telopeptideoftypeIcollagen,PTHParathyroidhormone,25OHDSerum25(OH)D,BDNFBrain-derivedneurotrophicfactor,BMIBodymassindex,BMDBonemineraldensity,WHRWaist/hipratio,ASMIAppendicularskeletalmassindexDuetal.BMCGeriatrics         (2021) 21:542 Page5of10

inducedbylowmusclemassandfunction.However,highfollistatininhibitsmyostatin-mediatedmusclewast-ing[20].Wealsofoundthatmyostatinpositivelycorre-latedwithfatmass.Severallinesofevidencesuggestthatobesityposesathreattoskeletalmusclehealthviamyos-tatin[21].Extremelyobesewomensecreteandexpressincreasedamountsofmyostatininskeletalmuscle,whichcorrelatewithinsulinresistance[22].Theexpres-sionofmyostatindecr

---

### Chunk 11/30
**Article:** Serum concentrations of oxytocin, DHEA and follistatin are associated with osteoporosis or sarcopenia in community-dwelling postmenopausal women (2021)
**Journal:** BMC Geriatrics
**Section:** other | **Similarity:** 0.482

rcopeniawasbasedonappendicularskeletalmusclemass(ASM;kg)measurementsandwasnormalizedforheight[ASMI(AppendicularSkeletalMuscleMassIndex)=ASM/height2(kg/m2)].SarcopeniawasdefinedasmeetingtheAWGScriteria[18]andcategorizedusingthefollowingthresholdvalues:(1)LowmusclemasswasASMI<5.4kg/m2;(2)Lowmusclestrengthwashandgripstrength<18kg;and(3)Poorphysicalperformancewasgaitspeeds<0.8m/sbya6-mwalktest.AccordingtotheWorldHealthOrganization(WHO)definition[15],osteoporosiswasdefinedasaT-scoreofBMD‚â§‚àí2.5forvertebral,femurneckortotalhip,havingexperiencedalow-traumahiporvertebralfracture,orhavingosteopeniabyBMDwhosustainedalow-traumaproximalhumerus,pelvis,ordistalforearmfracture.Osteosarcopeniaisthecombinationofsarcope-niaandosteoporosis.LaboratoryanalysesSerumsampleswerecollectedbetween0700and0900haftera10-hfast,andfreshlyseparatedserumwasdi-videdinto0.5-mlaliquotsandstoredat‚àí80¬∞C.Serumlevelsoffollistatin,myostatin,BDNFandoxytocinweremeasuredusingQuantikineELISA(R&DSystems,Min-neapolis,MN,USA),wi

---

### Chunk 12/30
**Article:** MFI - Reposi√ß√£o Hormonal - AULA 03 (2024)
**Journal:** Pos Graduacao MFI
**Section:** introduction | **Similarity:** 0.481

   ao contexto de baixa androg√™nica.
   - Objetivo: testosterona no quartil superior, DHT coerente, estradiol mais baixo, mantendo equival√™ncia proporcional. N√£o olhar valores isoladamente; correlacionar com sintomas e sinais.
* Fra√ß√£o livre e confiabilidade
   - Testosterona livre tem limita√ß√µes de m√©todo; fra√ß√£o total e livre devem ser interpretadas com cautela. A experi√™ncia cl√≠nica e correla√ß√£o multidimensional s√£o essenciais.
### 7. Ritmo circadiano, repeti√ß√£o de medidas e alimenta√ß√£o
* Hor√°rio e jejum
   - Homens 30‚Äì40 anos: testosterona 20‚Äì25% mais baixa √†s 16h versus 8h; preferir medir pela manh√£ em jejum para ver o pico.
   - 15% dos homens podem ter n√≠veis baixos em 24h naturalmente; acima dos 65 anos, muitos ter√£o baixos √†s 16h e normais √†s 8h. O exame √© ‚Äúuma foto‚Äù; repetir em condi√ß√µes padronizadas pode ser necess√°rio.

---

### Chunk 13/30
**Article:** Serum concentrations of oxytocin, DHEA and follistatin are associated with osteoporosis or sarcopenia in community-dwelling postmenopausal women (2021)
**Journal:** BMC Geriatrics
**Section:** results | **Similarity:** 0.481

osesathreattoskeletalmusclehealthviamyos-tatin[21].Extremelyobesewomensecreteandexpressincreasedamountsofmyostatininskeletalmuscle,whichcorrelatewithinsulinresistance[22].Theexpres-sionofmyostatindecreasedsignificantlydecreasedaftergastricsurgery,andinsulinresistancewassignificantlyimproved[23].Thisevidencesupportsthehypothesisthatobesityleadstoanincreaseinmyostatin,whichimpairsskeletalmusclehealth.Themainstrengthofthecurrentstudywasthatitsimultaneouslyconsideredtherelationshipbetweensev-eralbiomarkers,includingmyostatin,follistatin,oxyto-cin,BDNF,DHEA,T2andE2,andosteoporosisand/orsarcopeniainthesamestudypopulation.Therefore,thedegreeofcorrelationsbetweendifferentbiomarkersandboneandmusclewerecompared.Forthebiomarkersrelatedtosexhormones,ourstudyshowedthatDHEAwaspositivelyrelatedtohandgripandgaitspeed.Furtherresultsshowedthatpostmeno-pausalwomenwithsarcopeniaweremorelikelytohavehigherDHEAlevels.However,T2andE2werenotre-latedtomusclemass,gripstrengthorgaitspeed.Theseresultssuggestedthat

---

### Chunk 14/30
**Article:** Fisiologia End√≥crina Feminina (2024)
**Journal:** Pos Graduacao MFI
**Section:** discussion | **Similarity:** 0.480

incluindo:
  - Fogachos (calores) e sudoreses noturnas; dist√∫rbios do sono/ins√¥nia.
  - Ansiedade, depress√£o, baixa disposi√ß√£o/energia; redu√ß√£o de mem√≥ria e vitalidade.
  - Dor articular; olho seco; ressecamento vaginal; dispareunia; baixa libido.
  - Altera√ß√µes menstruais (polimenorreia com ciclos encurtados; per√≠odos de amenorreia).
  - S√≠ndrome geniturin√°ria da p√≥s-menopausa; sintomas urogenitais (incontin√™ncia, risco de prolapso).
  - Sarcopenia/perda de massa e t√¥nus muscular.
  - Altera√ß√µes cut√¢neas (queda de col√°geno; pele mais fl√°cida).
  - Mudan√ßas metab√≥licas (‚Üë triglic√©rides, colesterol, leptina).
- Discuss√£o sobre decl√≠nio da fertilidade com a idade, janela √≥tima de maternidade entre 20‚Äì30 anos e posterga√ß√£o da maternidade.
## Objetivo:
- N√£o h√° exame f√≠sico, laboratoriais ou de imagem de uma paciente espec√≠fica.

---

### Chunk 15/30
**Article:** Serum concentrations of oxytocin, DHEA and follistatin are associated with osteoporosis or sarcopenia in community-dwelling postmenopausal women (2021)
**Journal:** BMC Geriatrics
**Section:** other | **Similarity:** 0.476

ResClinPract.2017;11(2):177‚Äì87.https://doi.org/10.1016/j.orcp.2016.04.003.4.PicettiD,FosterS,PangleAK,SchraderA,GeorgeM,WeiJY,etal.Hydrationhealthliteracyintheelderly.NutrHealthyAging.2017;4(3):227‚Äì37.https://doi.org/10.3233/NHA-170026.5.CurcioF,FerroG,BasileC,LiguoriI,ParrellaP,PirozziF,etal.Biomarkersinsarcopenia:amultifactorialapproach.ExpGerontol.2016;85:1‚Äì8.https://doi.org/10.1016/j.exger.2016.09.007.6.EastellR,SzulcP.Useofboneturnovermarkersinpostmenopausalosteoporosis.LancetDiabetesEndocrinol.2017;5(11):908‚Äì23.https://doi.org/10.1016/S2213-8587(17)30184-5.7.McPherronAC,LawlerAM,LeeSJ.RegulationofskeletalmusclemassinmicebyanewTGF-betasuperfamilymember.Nature.1997;387:83‚Äì90.8.FifeE,KostkaJ,Kroc≈Å,GuligowskaA,Pig≈ÇowskaM,So≈ÇtysikB,etal.Relationshipofmusclefunctiontocirculatingmyostatin,follistatinandGDF11inolderwomenandmen.BMCGeriatr.2018;18(1):200.https://doi.org/10.1186/s12877-018-0888-y.9.ChoiK,JangHY,AhnJM,HwangSH,ChungJW,ChoiYS,etal.Theassociationoftheserumlevelsofm

---

### Chunk 16/30
**Article:** Serum concentrations of oxytocin, DHEA and follistatin are associated with osteoporosis or sarcopenia in community-dwelling postmenopausal women (2021)
**Journal:** BMC Geriatrics
**Section:** other | **Similarity:** 0.475

I:Appendicularskeletalmassindex;AWGS:AsianWorkingGroupforSarcopenia;BDNF:Brain-derivedneurotrophicfactor;BMD:Bonemineraldensity;BMI:Bodymassindex;CI:Confidenceintervals;COPD:Chronicobstructivepulmonarydisease;CT:Computedtomography;CTX:C-telopeptidecollagencrosslinks;CV:Coefficientsofvariance;DHEA:Dehydroepiandrosterone;DXA:DualenergyX-rayabsorptiometry;E2:Estradiol;FSH:Folliclestimulatinghormone;LH:Luteinizinghormone;MRI:Magneticresonanceimaging;OR:Oddsratios;P1NP:N-terminalpropeptideoftype1collagen;PTH:Parathyroidhormone;SHBG:Sexhormone-bindingglobulin;SPPB:Shortphysicalperformancebattery;T2:Testosterone;TGF-Œ≤:Transforminggrowthfactor-beta;WHO:WorldHealthOrganization
Table4Correlationofhistoryoffragilefracture,lifestyleandserumbiomarkerswithosteoporosisorsarcopeniabyLogisticRegressionVariablesOsteoporosisSarcopeniaOR(95%CI)PvalueOR(95%CI)P-valueHistoryoffragilefracture(novs.fracture)0.30(0.05‚Äì0.71)0.0060.45(0.01‚Äì0.86)0.015Physicalexercise(novs.high)0.97(0.44‚Äì3.13)0.941.07(0.24 

---

### Chunk 17/30
**Article:** Testosterone in women‚Äîthe clinical significance (2026)
**Journal:** Revista n√£o identificada
**Section:** other | **Similarity:** 0.474

pointsAnkle brachial indexMaggio et al (2012)32502 postmenopausal 
womenPopulation based75¬∑6 years (7¬∑1)Ankle brachial index <0¬∑9Total testosterone (higher vs lower log testosterone), OR 2¬∑00 (95% CI 1¬∑1‚Äì3¬∑47; p=0¬∑01); no signiÔ¨Å cant associations for SHBG or oestradiolCarotid arteryBernini et al (1999)33101 premenopausal 
and postmenopausal 
womenConvenience 
sample46¬∑7 years (10¬∑35)cCIMTSigniÔ¨Å cant independent inverse relation between free testosterone and maximal total cCIMT (p<0¬∑008), androstenedione and mean 
cCIMT (p<0¬∑03), and androstenedione and maximal cCIMT (p<0¬∑05); 
age, BMI, and blood pressure were also inversely related to cCIMTGolden et al 
(2002)34182 postmenopausal 
cases and 
182 postmenopausal 
controls Case-control61¬∑6 yearsCIMTIn the fully adjusted model (highest vs lowest quartile): total 
testosterone, OR 0¬∑34 (95% CI 0¬∑16‚Äì0¬∑70; p=0¬∑004); SHBG, OR 0¬∑48 
(0¬∑24‚Äì0¬∑97).

---

### Chunk 18/30
**Article:** MFI - Reposi√ß√£o Hormonal - AULA 03 (2024)
**Journal:** Pos Graduacao MFI
**Section:** results | **Similarity:** 0.473

vida.
   - Em materiais did√°ticos do Dr. Merwin/Morgan Taylor, resultados foram apresentados como sem aumento de risco (‚Äúharmful zero‚Äù) e com benef√≠cios gerais na reposi√ß√£o quando bem indicada.
* Preven√ß√£o vs tratamento agudo
   - A testosterona n√£o ‚Äúsalva‚Äù no evento agudo (infarto), mas pode ter papel preventivo ao melhorar fatores de risco e estado geral (ex.: composi√ß√£o corporal, energia, bem-estar).
### 4. Avalia√ß√£o cl√≠nica e question√°rios
* Ferramentas de triagem
   - Question√°rios citados: St. Louis University (ADAM), AMS, MMAS, HRS. Podem ser baixados, mas o instrutor considera desnecess√°rios como √∫nico crit√©rio, devido √† ampla inespecificidade dos sintomas.
* Sintomas e sinais de baixa testosterona
   - Homens: irritabilidade, fadiga, baixa libido, diminui√ß√£o de pelos nas pernas, depress√£o, sarcopenia, aumento de gordura (principalmente abdominal), ins√¥nia, disfun√ß√£o er√©til.

---

### Chunk 19/30
**Article:** Emagrecimento - Parte VII (2024)
**Journal:** Pos Graduacao MFI
**Section:** results | **Similarity:** 0.472

3.  **Exerc√≠cio F√≠sico:** Potencializa os resultados.
    4.  **Movimento e Rela√ß√µes Saud√°veis:** Incluindo a necessidade de terapia.
    5.  **Conex√£o com a Natureza:** Contato com o ambiente natural para sa√∫de mental e espiritual.
*   **Colabora√ß√£o Multidisciplinar:** O emagrecimento eficaz exige a colabora√ß√£o com um nutricionista. Os pacientes devem ser incentivados a investir nesse acompanhamento profissional.
## ‚ùì Perguntas
- [Inserir Pergunta/Confus√£o]
## üìö Tarefas
- [ ] 1. Educar os pacientes sobre a adipog√™nese e a "mem√≥ria corporal" para o ganho de peso, usando analogias como a do bal√£o.
- [ ] 2. Solicitar o exame de Prote√≠na C Reativa ultrassens√≠vel (PCR-us) como marcador de inflama√ß√£o sist√™mica, independentemente da especialidade.
- [ ] 3. Para pacientes com baixo metabolismo (especialmente mulheres), considerar uma estrat√©gia inicial focada no ganho de massa muscular antes de focar na perda de peso.
- [ ] 4.

---

### Chunk 20/30
**Article:** Serum concentrations of oxytocin, DHEA and follistatin are associated with osteoporosis or sarcopenia in community-dwelling postmenopausal women (2021)
**Journal:** BMC Geriatrics
**Section:** results | **Similarity:** 0.472

otrophicfactor,BMDBonemineraldensity,BMIBodymassindex,ASMIAppendicularskeletalmassindexDuetal.BMCGeriatrics         (2021) 21:542 Page7of10

OurresultsshowedthatvitaminDdeficiencywasverycommonintheChinesepopulation.Wepreviouslypub-lishedarelevantarticle[16].ManystudiesshowedthatvitaminDwascloselyrelatedtomusclesandbones.Notably,ourresultsshowedthatexcludingtheinfluenceofvitaminD,oxytocinwasalsoassociatedwithosteo-porosis,andfollistatinandDHEAwereassociatedwithsarcopenia.Inourstudy,milkconsumption(<50mL/dayvs.‚â•250mL/day)(OR6.32;95%CI1.04‚Äì38.29;p=0.045)wasassociatedwithsarcopenia.Thereasonisthatmilkcontainsnutrients,especiallywheyprotein,thatmaybemyoprotective.Onetrialinvestigatedtheeffectofaddingmilkproteintothehabitualdietonskeletalmusclemass,strength,andphysicalperformanceinMexicanelderlyindividualswithoutsarcopenia.Theresultsshowedthatconsumptionmayreducetheriskofsarco-peniabyimprovingskeletalmusclemassduetotheadditionofnutrient-richdairyproteinstothehabitualdiet[36].However,curr

---

### Chunk 21/30
**Article:** Exercise as medicine ‚Äì evidence for prescribing exercise as therapy in 26 different chronic diseases (2026)
**Journal:** Revista n√£o identificada
**Section:** discussion | **Similarity:** 0.471

tricindicators
andhipfracture.TheNHANESIepidemiologicfollow-upstudy.JAmGeriatrSoc1989:37:9‚Äì16.FarrellSW,FinleyCE,GrundySM.CardiorespiratoryÔ¨Åtness,LDLcholesterol,andCHDmortalityinmen.MedSciSportsExerc2012:44:
2132‚Äì2137.FaulknerG,CohnT,RemingtonG.Validationofaphysicalactivityassessmenttoolforindividualswith
schizophrenia.SchizophrRes2006:
82:225‚Äì231.FebbraioMA,PedersenBK.Muscle-derivedinterleukin-6:mechanisms
foractivationandpossiblebiologicalroles.FASEBJ2002:16:1335‚Äì1347.FelsonDT,NaimarkA,AndersonJ,KazisL,CastelliW,MeenanRF.Theprevalenceofkneeosteoarthritisintheelderly.TheFramingham
OsteoarthritisStudy.Arthritis
Rheum1987:30:914‚Äì918.FillitH,NashDT,RundekT,ZuckermanA.Cardiovascularrisk
factorsanddementia.AmJGeriatrPharmacother2008:6:100‚Äì118.FirthJ,CotterJ,ElliottR,FrenchP,YungAR.Asystematicreviewand
meta-analysisofexerciseinterventionsinschizophreniapatients.PsycholMed2015:45:
1343‚Äì1361.FitzgeraldGK,PivaSR,IrrgangJJ,BouzubarF,StarzTW.Quadricepsactivationfailureasamoderato

---

### Chunk 22/30
**Article:** Serum concentrations of oxytocin, DHEA and follistatin are associated with osteoporosis or sarcopenia in community-dwelling postmenopausal women (2021)
**Journal:** BMC Geriatrics
**Section:** methods | **Similarity:** 0.471

exhor-monesarecloselyrelatedtobonemass,musclemassandstrengthandpredictiveriskfactorsforboneandmusclelossintheelderly.Thecurrentstudyenrolledhealthycommunity-dwellingpostmenopausalwomenaged50‚Äì90.Wecol-lectedhistoryoffragilityfracture,evaluatedbonemass,musclemassandstrength,andmeasuredsexhormones,myokinesandboneturnovermarkers(1)toexaminethechangesinthesebiomarkerswithage,(2)examinetherelationshipbetweenthesebiomarkersandbonemass,musclemassandstrength,and(3)identifypotentialbio-markersforthescreeninganddiagnosingofosteopor-osisandsarcopeniainpostmenopausalwomen.MethodsStudygroupWedesignedacross-sectionalstudybyopenadver-tisementfromcommunityhealthservicesin2019‚Äì2020torecruithealthypostmenopausalwomenwhohadenteredmenopauseforlongerthan1year.Afterexcludingsubjectswhohadahistoryofamen-orrhea(n=8),ovariectomy(n=15),heartdisease(n=4),rheumatoidarthritis(n=8),chronicob-structivepulmonarydisease(COPD)(n=21),andthyroiddisease(n=13),thestudycohortincluded478women.Allparticipantswerehealthy,an

---

### Chunk 23/30
**Article:** Dislipidemias II (2024)
**Journal:** Pos Graduacao MFI
**Section:** results | **Similarity:** 0.469

dade, inatividade f√≠sica, press√£o arterial e dislipidemia.
- A inflama√ß√£o √© indicada por marcadores como a Prote√≠na C-Reativa (PCR), onde um valor de 5 j√° √© considerado elevado, e a Interleucina 6 (exemplo de paciente com 8.45).
- A resposta anti-inflamat√≥ria √© medida pela Interleucina 10, com um valor de corte de 3,5 (abaixo disso √© um risco) e um exemplo de paciente com 6.44.
- A sa√∫de do endot√©lio √© avaliada pelo √≥xido n√≠trico, que deve estar em 8.8; um paciente com 4.8 j√° apresenta disfun√ß√£o sist√™mica.
- A LDL oxidada √© um marcador cr√≠tico, com um limite saud√°vel de 133, enquanto pacientes de alto risco podem apresentar valores extremos, como 1000.
**Achados Adicionais**
- Existem cinco par√¢metros cl√°ssicos para definir a s√≠ndrome metab√≥lica.
- O alvo de LDL para pacientes de alto risco, segundo as diretrizes atuais, √© de 50.

---

### Chunk 24/30
**Article:** Serum concentrations of oxytocin, DHEA and follistatin are associated with osteoporosis or sarcopenia in community-dwelling postmenopausal women (2021)
**Journal:** BMC Geriatrics
**Section:** other | **Similarity:** 0.469

.4%forCTXandbelow2.6and4.1%forP1NP,below2.7and6.5%forPTH,andbelow7.8and10.7%for25(OH)D.StatisticsSPSSv23(SPSSInc.,Chicago,IL,USA)wasusedtoanalyzethedata.KolmogorovSmirnovmethodwasusedtotestthenormaldistributionofdata.Continuousvari-ableswereexpressedasthemeanswithstandarddevi-ation,medianwithinterquartilerange(25‚Äì75%),andclassificationvariableswereexpressedaspercentages.DifferencesbetweengroupswereanalyzedusingANOVA,Kruskal-WallisHtestorPearson‚Äôschi-squaredDuetal.BMCGeriatrics         (2021) 21:542 Page3of10

testforcontinuousandcategoricalvariables,respect-ively.AftertheresidualwastestedbyExplore,multivari-atelinearregressionmodelswereconstructedtoanalyzethecorrelationbetweendependentvariables,suchasgripstrength,gaitspeed,leanmass,fatmass,ASMI,bonemass,andindependentcontinuouspredictors,suchasserummyokines,sexhormones,andboneturnovermarkers.Associationsbetweenhistoryoffragilityfrac-ture,lifestyle,serumbiomarkersandosteoporosisandsarcopeniawereanalyzedusinglogisticregressionana-lys

---

### Chunk 25/30
**Article:** Serum concentrations of oxytocin, DHEA and follistatin are associated with osteoporosis or sarcopenia in community-dwelling postmenopausal women (2021)
**Journal:** BMC Geriatrics
**Section:** discussion | **Similarity:** 0.469

iablesOsteoporosisSarcopeniaOR(95%CI)PvalueOR(95%CI)P-valueHistoryoffragilefracture(novs.fracture)0.30(0.05‚Äì0.71)0.0060.45(0.01‚Äì0.86)0.015Physicalexercise(novs.high)0.97(0.44‚Äì3.13)0.941.07(0.24‚Äì2.51)0.69Milkconsumption(novs.high)1.39(0.57‚Äì3.34)0.466.32(1.04‚Äì38.29)0.045DHEA(ng/ml)0.75(0.61‚Äì1.05)0.060.73(0.51‚Äì0.96)0.032T20.89(0.63‚Äì1.24)0.620.78(0.44‚Äì2.22)0.72E20.67(0.33‚Äì2.65)0.580.90(0.46‚Äì3.12)0.65PTH(pg/ml)1.01(0.97‚Äì1.04)0.640.97(0.90‚Äì1.04)0.3625OHD(ng/ml)0.98(0.93‚Äì1.07)0.220.51(0.11‚Äì0.82)0.047CTX(pg/ml)1.02(0.98‚Äì1.05)0.171.02(0.92‚Äì1.12)0.78PINP(ng/ml)1.12(0.97‚Äì1.48)0.511.07(0.95‚Äì1.17)0.31Follistatin(ng/ml)1.08(0.56‚Äì2.09)0.171.66(1.19‚Äì3.57)0.022Myostatin(ng/ml)0.95(0.90‚Äì1.13)0.821.01(0.98‚Äì1.03)0.56BDNF(ng/ml)0.78(0.38‚Äì1.62)0.500.35(0.07‚Äì1.82)0.35Oxytocin(pg/ml)0.75(0.63‚Äì0.98)0.0190.88(0.57‚Äì1.01)0.14Multivariatelogisticanalysiswasperformedafteradjustingforage.DHEADehydroepiandrosterone,PTHParathyroidhormone,CTXC-telopeptidecollagenc

---

### Chunk 26/30
**Article:** Serum concentrations of oxytocin, DHEA and follistatin are associated with osteoporosis or sarcopenia in community-dwelling postmenopausal women (2021)
**Journal:** BMC Geriatrics
**Section:** results | **Similarity:** 0.467

erlyindividualswithoutsarcopenia.Theresultsshowedthatconsumptionmayreducetheriskofsarco-peniabyimprovingskeletalmusclemassduetotheadditionofnutrient-richdairyproteinstothehabitualdiet[36].However,currentevidencedoesnotshowbeneficialeffectsofmilkonmusclehealthinolderadults.Thisdiscrepancymaybeduetohighhabitualproteinintakes(>1.0g/kgBW/d)instudyparticipants[37].Ourstudydidnotcalculatethetotalhabitualpro-teinintakeofthesubjects,andtheresultshavecertainlimitations.Ourstudyhasseveralotherlimitations.First,were-cruitedhealthypostmenopausalwomenfromcommu-nityhealthservices.Therefore,theconclusionsfromourdatamaynotbeapplicabletomenandunhealthyindi-viduals.Second,thiscross-sectionalstudydoesnotallowustoobtaincausalrelationships.Longitudinalstudiesshouldbeperformedtofurtherexaminethepredictiveeffectofcirculatingbiomarkersforosteoporosisandsarcopenia.Insummary,thecurrentstudyisthefirststudytoex-ploretherelationshipsbetweenserummyokines,sexhormones,boneturnovermarkers,bonemass,musclemass,andmuscle

---

### Chunk 27/30
**Article:** Adrenal Androgens and Aging (2023)
**Journal:** Endotext
**Section:** results | **Similarity:** 0.467

composition with metabolism and disease. J Nutr Health Aging 2005;9:408‚Äì419
86. Berkman LF, Seeman TE, Albert M et al. High, usual and impaired functioning in
community-dwelling older men and women: Findings from the MacArthur Foundation
Research Network on Successful Aging. 
J Clin Epidemiol 1993;46:1129‚Äì1140
87. Morrison MF, Katz IR, Parmelee P et al. 
Dehydroepiandrosterone sulfate (DHEA-S) and
psychiatric and laboratory measures of frailty in a residential care population. Am J Geriatr
Psychiatry 1998;6:277‚Äì284
88. Abbasi A, Duthie EH, Sheldahl L et al. Association of dehydroepiandrosterone sulfate,
body composition, and physical fitness in independent communitydwelling older men and
women. J Am Geriatr Soc 1998;46:263‚Äì273
89. Clarke BL, Ebeling PR, Jones JD, Wahner HW, O‚ÄôFallon WM, Riggs BL, Fitzpatrick LA.
Predictors of bone mineraldensity in aging healthy men varies by skeletal site. Calcified Tiss
Int 2002;70:137‚Äì145
90.

---

### Chunk 28/30
**Article:** Carboidratos IV (2024)
**Journal:** Pos Graduacao MFI
**Section:** discussion | **Similarity:** 0.467

cose, evidenciando resist√™ncia perif√©rica √† insulina.
- A an√°lise isolada da glicemia de jejum pode levar a um diagn√≥stico incorreto de "sobrepeso saud√°vel", mascarando um problema metab√≥lico grave.
> **Sugest√µes da IA**
> O uso deste estudo de caso foi fundamental para traduzir a teoria em pr√°tica. Voc√™ demonstrou de forma excelente por que a glicemia de jejum isolada √© insuficiente. Ao apresentar os dados da curva, seria √∫til destacar verbalmente os valores de pico da insulina e da glicose e compar√°-los com os valores de refer√™ncia ideais, para que os alunos compreendam imediatamente a magnitude do problema. A sua cr√≠tica √† miopia do diagn√≥stico de "gordinho saud√°vel" foi muito pertinente e memor√°vel.
### 8. Estudo de Caso 2: Paciente Feminina com M√∫ltiplas Comorbidades e Hipoglicemia de Rebote
- Paciente: 71 anos, 1,54m, 87 kg, com m√∫ltiplas queixas (dores, alergias, depress√£o, hipertens√£o, etc.) e polifarm√°cia (incluindo estatina e Saxenda).

---

### Chunk 29/30
**Article:** Fisiologia End√≥crina Feminina (2024)
**Journal:** Pos Graduacao MFI
**Section:** other | **Similarity:** 0.464

h√° exame f√≠sico, laboratoriais ou de imagem de uma paciente espec√≠fica. S√£o apresentados conceitos fisiol√≥gicos e dados t√©cnicos:
  - Menopausa: diagn√≥stico retrospectivo ap√≥s 12 meses de amenorreia; data definida pela √∫ltima menstrua√ß√£o. Idade m√©dia no Brasil ~51 anos; irregularidade de ciclos por volta de 45‚Äì46 anos.
  - Reserva ovariana:
    - Queda quantitativa e qualitativa dos fol√≠culos ovarianos com a idade (maior perda entre 30‚Äì40 anos; aos 50 anos ~70% dos fol√≠culos de baixa qualidade).
    - Horm√¥nio Anti-M√ºlleriano (AMH) declina com a idade; exemplos:
      - AMH 0,14 ng/mL aos 32 anos ~ percentil 5; menopausa m√©dia predita ~48 anos (faixa ~42‚Äì53).
      - Regra pr√°tica em reprodu√ß√£o assistida: AMH x 10 ‚âà n√∫mero esperado de fol√≠culos por ciclo (ex.: 0,1 ‚Üí ~1 fol√≠culo).

---

### Chunk 30/30
**Article:** Aula J√©ssica Marques - Neurologia Funcional Integrativa 3 (2024)
**Journal:** Pos Graduacao MFI
**Section:** results | **Similarity:** 0.464

agn√©sio, vitamina B12, folato (B9), vitamina D e ferritina/ferro; corrigir defici√™ncias conforme resultados.
- [ ] 3. Planejar introdu√ß√£o gradual de suplementa√ß√£o: iniciar uma formula√ß√£o, aguardar 2‚Äì3 dias, adicionar a segunda e, ap√≥s 2‚Äì3 dias, a terceira, monitorando efeitos colaterais.
- [ ] 4. Implementar ciclos de 60‚Äì90 dias entre plantas com mecanismos semelhantes, trocando para outra fam√≠lia ap√≥s cada ciclo para sensibilizar diferentes receptores.
- [ ] 5. Selecionar extratos padronizados com maior biodisponibilidade (ex.: Curcumin C3, Cureit, CurcuVail) e evid√™ncia cl√≠nica para compor formula√ß√µes.
- [ ] 6. Incorporar vias alternativas para idosos: avaliar uso de injet√°veis, transd√©rmicos, fotobiomodula√ß√£o, aromaterapia e tinturas conforme perfil e poder aquisitivo.
- [ ] 7. Estruturar rotina di√°ria do paciente com atividades √∫teis e significativas (cozinhar, organizar casa, acompanhar netos/filhos), promovendo pertencimento e utilidade.
- [ ] 8.

---

